Austrian Court Hands Ranbaxy Lipitor Win
In a boost for Ranbaxy Laboratories Ltd., an Austrian court has upheld an earlier decision invalidating Pfizer Inc.'s patent on Lipitor, enabling the Indian generic drug maker to push forward in...To view the full article, register now.
Already a subscriber? Click here to view full article